The influence of apoptosis in intestinal barrier integrity in rats

Scandinavian Journal of Gastroenterology

Volumn 33, Issue 4, 1998, Pages 415-422

  Sun, Z ^b   Wang, X ^b   Wallen, R ^b   Deng, X ^b   Du, X ^b   Hallberg, E ^b   Andersson, R ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

Apoptosis; Cycloheximide; Deoxy D glucose; Doxorubicin; Intestine; Permeability; Rat

Indexed keywords

CYCLOHEXIMIDE; DEOXYGLUCOSE; DOXORUBICIN; HUMAN SERUM ALBUMIN; SODIUM CHLORIDE; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; EPITHELIUM CELL; GLYCOLYSIS; INTESTINE EPITHELIUM; INTESTINE MUCOSA PERMEABILITY; MALE; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; WATER CONTENT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES; APOPTOSIS; CELL MEMBRANE PERMEABILITY; CYCLOHEXIMIDE; DEOXYGLUCOSE; DOXORUBICIN; ENDOTHELIUM; EPITHELIAL CELLS; HUMANS; INTESTINAL MUCOSA; IODINE RADIOISOTOPES; MALE; MICROSCOPY, ELECTRON; PROTEIN SYNTHESIS INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; SERUM ALBUMIN;

EID: 0031922348     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365529850171053     Document Type: Article

References (21)

1. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. J Cancer 1972;26:239-57.
2. Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 1995;146:3-15.
3. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-62.
4. Arai T, Kida Y, Harmon BV, Gobe GC. Comparative alterations in p53 expression and apoptosis in the irradiated rat small and large intestine. Br J Cancer 1996;74:406-12.
5. Moss SF, Attia L, Scholes JV, Walters JRF, Holt PR. Increased small intestinal apoptosis in coeliac disease. Gut 1996;39:811-7.
6. Watson AJM. Necrosis and apoptosis in the gastrointestinal tract. Gut 1995;37:165-7.
7. Que FG, Gores GJ. Cell death by apoptosis: basic concepts and disease relevance for the gastroenterologist. Gastroenterology 1996;110:1238-43.
8. Bjarnason I, Macpherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology 1995;108:1566-81.
9. Sanderson IR, Walker WA. Uptake and transport of macromolecule by the intestine. Possible role in clinical disorders. Gastroenterology 1993;104:622-39.
10. Thakkar NS, Potten CS. Inhibition of doxorubicin-induced apoptosis in vivo by 2-deoxy-d-glucose. Cancer Res 1993;53: 2057-60.
11. Kuhes P. Ischemia-reperfusion in feline small intestine: a role for nitric oxide. Am J Physiol 1993;264:G143-9.
12. Kubes P, Ibbotson G, Russell JB, Wallace JL, Granger DN. Role of platelet-activating factor in reperfusion-induced leukocyte adherence. Am J Physiol 1990;258:G300-5.
13. Gavrieli Y, Sherman Y, BenSasson SA. Identification of programmed death via specific labelling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
14. Shu S, Ju G, Fan L. The glucose oxidase-DAB-nickle method in peroxidase histochemistry of the nervous system. Neurosci Lett 1988;85:169-71.
15. Bedi A, Pasricha PJ, Akhtar AJ, Barber GC, Gliardiello FM, Giardiello FM, et al. Inhibition of apoptosis during development of colorectal cancer. Cancer Res 1995;55:1811-6.
16. Thakkar NS, Potten CS. Abrogation of adriamycin toxicity in vivo by cycloheximide. Biochem Pharmacol 1992;43:1683-91.
17. Holm B, Jensen PB, Sehested M, Hansen HH. In vivo inhibition of etoposide-mediated apoptosis, toxicity, and antitumor effect by the topoisomerase II-uncoupling anthracycline aclarubicin. Cancer Chemother Pharmacol 1994;34:503-8.
18. Tewey KM, Rowe TC, Young L, Halligan BD, Liu LF. Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science 1984;266:466-8.
19. Chow KC, King CK, Ross WE. Abrogation of etoposide-mediated cytotoxicity by cycloheximide. Biochem Pharmacol 1988;37:1117-22.
20. Lee FD. Importance of apoptosis in the histopathology of drug related lesions in the small intestine. J Clin Pathol 1993;46:118-22.
21. Mansi J, Ellis E, Viner C, Mundy J, Millar J, Milan S, et al. Gut protection by cyclophosphamide 'priming' in patients receiving high-dose melphalan-effect of drug scheduling. Cancer Chemother Pharmacol 1992;30:149-51.